Lobbying client
COGNITION THERAPEUTICS, INC.
small molecule therapeutics targeting degenerative diseases of the human brain
Filings
4
Filed by
1
Reported in-house
—
Reported by firms
—
Filings
4 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination (No Activity) 4th Quarter 2012
|
G2G CONSULTING | — reported |
|
3rd Quarter - Report 3rd Quarter 2012
|
G2G CONSULTING | — reported |
|
2nd Quarter - Report 2nd Quarter 2012
|
G2G CONSULTING | — reported |
|
Registration 2nd Quarter 2012
|
G2G CONSULTING | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| G2G CONSULTING | 3 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Budget/Appropriations | BUD | 3 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.